(Q45737326)

English

Differential recognition of epitopes present on monomeric and oligomeric forms of gp160 glycoprotein of human immunodeficiency virus type 1 by human monoclonal antibodies

scientific article published in May 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Differential recognition of epitopes present on monomeric and oligomeric forms of gp160 glycoprotein of human immunodeficiency virus type 1 by human monoclonal antibodies (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

1 reference

based on heuristic

inferred from title

author name string

G Zeder-Lutz

1

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

J Hoebeke

2

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

M H Van Regenmortel

3

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

language of work or name

0 references

publication date

1 May 2001

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

268

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

2856-2866

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Overview: practical insights from comparative immunology and pathogenesis of AIDS, hepatitis B, and measles for developing an HIV vaccine

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.02167.X

21 January 2018

Why do we not have an HIV vaccine and how can we make one? .

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.02167.X

21 January 2018

Prospect for prevention of human immunodeficiency virus infection: purified 120-kDa envelope glycoprotein induces neutralizing antibody

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.02167.X

21 January 2018

Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.02167.X

21 January 2018

Neutralization of Divergent HIV-1 Isolates by Conformation-Dependent Human Antibodies to Gp120

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.02167.X

21 January 2018

Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.02167.X

21 January 2018

Neutralization of divergent human immunodeficiency virus type 1 variants and primary isolates by IAM-41-2F5, an anti-gp41 human monoclonal antibody

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.02167.X

21 January 2018

Molecular design versus empirical discovery in peptide-based vaccines. Coming to terms with fuzzy recognition sites and ill-defined structure-function relationships in immunology

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.02167.X

21 January 2018

Passive immunization with a human monoclonal antibody protects hu-PBL-SCID mice against challenge by primary isolates of HIV-1.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.02167.X

21 January 2018

Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.02167.X

21 January 2018

Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.02167.X

21 January 2018

Synergistic neutralization of HIV-1 by human monoclonal antibodies against the V3 loop and the CD4-binding site of gp120

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.02167.X

21 January 2018

Synergistic neutralization of a chimeric SIV/HIV type 1 virus with combinations of human anti-HIV type 1 envelope monoclonal antibodies or hyperimmune globulins

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.02167.X

21 January 2018

Neutralizing antibody directed against the HIV-1 envelope glycoprotein can completely block HIV-1/SIV chimeric virus infections of macaque monkeys.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.02167.X

21 January 2018

Recombinant human monoclonal antibody IgG1b12 neutralizes diverse human immunodeficiency virus type 1 primary isolates

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.02167.X

21 January 2018

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.02167.X

21 January 2018

Human immunodeficiency virus type 1 neutralization is determined by epitope exposure on the gp120 oligomer

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.02167.X

21 January 2018

Antibody and virus: binding and neutralization

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.02167.X

21 January 2018

HIV-1 tropism for mononuclear phagocytes can be determined by regions of gp120 outside the CD4-binding domain

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.02167.X

21 January 2018

Characterisation of a series of human immunodeficiency virus isolates derived sequentially from a single patient

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.02167.X

21 January 2018

Experimental design for kinetic analysis of protein-protein interactions with surface plasmon resonance biosensors.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.02167.X

21 January 2018

Oligomeric structure of the human immunodeficiency virus type 1 envelope glycoprotein

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.02167.X

21 January 2018

Real-time competitive kinetic analysis of interactions between low-molecular-weight ligands in solution and surface-immobilized receptors

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.02167.X

21 January 2018

Mutational analysis of the assembly domain of the HIV-1 envelope glycoprotein

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.02167.X

21 January 2018

Studies with crosslinking reagents on the oligomeric structure of the env glycoprotein of HIV.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.02167.X

21 January 2018

A Peptide from the Heptad Repeat of Human Immunodeficiency Virus gp41 Shows both Membrane Binding and Coiled-Coil Formation

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.02167.X

21 January 2018

A trimeric structural domain of the HIV-1 transmembrane glycoprotein.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.02167.X

21 January 2018

Atomic structure of the ectodomain from HIV-1 gp41

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.02167.X

21 January 2018

Core structure of gp41 from the HIV envelope glycoprotein

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.02167.X

21 January 2018

Modifications that stabilize human immunodeficiency virus envelope glycoprotein trimers in solution

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.02167.X

21 January 2018

Characterization of stable, soluble trimers containing complete ectodomains of human immunodeficiency virus type 1 envelope glycoproteins

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.02167.X

21 January 2018

A recombinant human immunodeficiency virus type 1 envelope glycoprotein complex stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits is an antigenic mimic of the trimeric virion-associated structure

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.02167.X

21 January 2018

Processing, stability, and receptor binding properties of oligomeric envelope glycoprotein from a primary HIV-1 isolate

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.02167.X

21 January 2018

Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.02167.X

21 January 2018

The antigenic structure of the HIV gp120 envelope glycoprotein

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.02167.X

21 January 2018

Oligomeric modeling and electrostatic analysis of the gp120 envelope glycoprotein of human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.02167.X

21 January 2018

Analysis of synergism/antagonism between HIV-1 antibody-positive human sera and soluble CD4 in blocking HIV-1 binding and infectivity

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.02167.X

21 January 2018

Synergistic interaction between ligands binding to the CD4 binding site and V3 domain of human immunodeficiency virus type I gp120

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.02167.X

21 January 2018

Synergistic inhibition of HIV-1 by CD4 binding domain reagents and V3-directed monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.02167.X

21 January 2018

The human immunodeficiency virus type 1 gp120 V2 domain mediates gp41-independent intersubunit contacts

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.02167.X

21 January 2018

CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.02167.X

21 January 2018

Cooperative subunit interactions within the oligomeric envelope glycoprotein of HIV-1: functional complementation of specific defects in gp120 and gp41.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.02167.X

21 January 2018

Evaluation of Monoclonal Antibodies to Human Immunodeficiency Virus Type 1 Primary Isolates by Neutralization Assays: Performance Criteria for Selecting Candidate Antibodies for Clinical Trials

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.02167.X

21 January 2018

Synergy between human monoclonal antibodies to HIV extends their effective biologic activity against homologous and divergent strains

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.02167.X

21 January 2018

Immobilization of proteins to a carboxymethyldextran-modified gold surface for biospecific interaction analysis in surface plasmon resonance sensors

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1327.2001.02167.X

21 January 2018

Identifiers

10.1046/J.1432-1327.2001.02167.X

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

release_7m43acveejhnvj3xfz7galmcsi

1 reference

https://api.fatcat.wiki/v0/release/7m43acveejhnvj3xfz7galmcsi

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45737326&oldid=2079836902"